HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Edward K Geissler Selected Research
Edward K Geissler Research Topics
Disease
68
Neoplasms (Cancer)
07/2022 - 01/2002
14
Neoplasm Metastasis (Metastasis)
01/2020 - 03/2004
13
Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 03/2004
11
Colitis
01/2021 - 01/2006
8
Melanoma (Melanoma, Malignant)
01/2022 - 09/2002
8
Hepatocellular Carcinoma (Hepatoma)
11/2020 - 07/2008
8
Colonic Neoplasms (Colon Cancer)
12/2010 - 01/2003
7
Inflammation (Inflammations)
01/2021 - 12/2006
7
Fibrosis (Cirrhosis)
01/2021 - 05/2007
6
Hypoxia (Hypoxemia)
04/2017 - 03/2007
5
Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 03/2004
5
Infections
01/2023 - 10/2002
5
Autoimmune Diseases (Autoimmune Disease)
01/2019 - 02/2008
5
Stomach Neoplasms (Stomach Cancer)
12/2015 - 03/2007
5
Carcinogenesis
11/2013 - 08/2009
3
Thrombosis (Thrombus)
03/2024 - 03/2004
3
Liver Diseases (Liver Disease)
02/2021 - 11/2008
3
Ischemia
02/2021 - 11/2004
3
Reperfusion Injury
02/2021 - 11/2004
3
Wounds and Injuries (Trauma)
11/2020 - 11/2005
3
Skin Neoplasms (Skin Cancer)
01/2015 - 11/2010
3
Fibrosarcoma
10/2012 - 05/2008
2
Adenocarcinoma
07/2022 - 04/2007
2
End Stage Liver Disease
03/2021 - 12/2015
2
Hepatitis
01/2021 - 01/2021
2
Graft vs Host Disease (Graft-Versus-Host Disease)
12/2019 - 10/2009
2
Ulcerative Colitis
06/2015 - 12/2006
2
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
02/2012 - 04/2010
2
Lymphatic Metastasis
11/2011 - 06/2007
2
Tyrosinemias (Tyrosinemia)
05/2010 - 11/2008
Drug/Important Bio-Agent (IBA)
21
Sirolimus (Rapamycin)
FDA Link
11/2020 - 02/2002
11
TOR Serine-Threonine Kinases
IBA
11/2020 - 06/2005
8
Transcription Factors (Transcription Factor)
IBA
06/2015 - 11/2007
8
Immunosuppressive Agents (Immunosuppressants)
IBA
11/2013 - 05/2004
7
Citric Acid (Citrate)
FDA Link
Generic
07/2022 - 01/2018
7
MTOR Inhibitors
IBA
11/2020 - 03/2008
7
Small Interfering RNA (siRNA)
IBA
12/2018 - 05/2007
7
Heat-Shock Proteins (Heat-Shock Protein)
IBA
07/2012 - 03/2007
6
Proteins (Proteins, Gene)
FDA Link
01/2021 - 09/2002
6
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2017 - 02/2002
6
Interleukin-13
IBA
04/2014 - 05/2007
5
Cyclosporine (Ciclosporin)
FDA Link
Generic
11/2013 - 02/2002
5
Dextrans (Dextran)
FDA Link
12/2011 - 01/2006
4
gluconic acid (gluconate)
FDA Link
Generic
07/2022 - 01/2018
4
Interleukin-6 (Interleukin 6)
IBA
01/2019 - 11/2007
4
Messenger RNA (mRNA)
IBA
02/2018 - 11/2005
4
sodium sulfate (sodium bisulfate)
FDA Link
Generic
05/2011 - 01/2006
4
IGF Type 1 Receptor (IGF 1 Receptor)
IBA
04/2010 - 11/2007
3
citrate-binding transport protein
IBA
07/2022 - 01/2018
3
Fatty Acids (Saturated Fatty Acids)
IBA
07/2022 - 01/2018
3
Immune Checkpoint Inhibitors
IBA
01/2022 - 01/2021
3
Cytokines
IBA
12/2020 - 05/2008
3
Lactic Acid (Lactate)
FDA Link
Generic
12/2019 - 11/2016
3
Mechanistic Target of Rapamycin Complex 2
IBA
12/2018 - 04/2010
3
RNA (Ribonucleic Acid)
IBA
01/2018 - 01/2006
3
Phosphotransferases (Kinase)
IBA
02/2016 - 07/2008
3
Sulfonic Acids
IBA
04/2014 - 05/2007
3
Mycophenolic Acid (Cellcept)
FDA Link
Generic
02/2013 - 09/2006
3
Epidermal Growth Factor (EGF)
IBA
10/2012 - 03/2007
3
Interleukins
IBA
12/2011 - 12/2008
3
Gemcitabine
FDA Link
11/2011 - 03/2004
3
Insulin-Like Growth Factor I (IGF-1)
IBA
12/2008 - 11/2007
3
ErbB Receptors (EGF Receptor)
IBA
11/2007 - 03/2007
3
17- (dimethylaminoethylamino)- 17- demethoxygeldanamycin
IBA
11/2007 - 03/2007
2
Antiviral Agents (Antivirals)
IBA
01/2023 - 01/2018
2
Collagen
IBA
01/2021 - 12/2008
2
Antigens
IBA
12/2020 - 01/2013
2
Calcineurin Inhibitors
IBA
11/2020 - 12/2006
2
Integrins
IBA
01/2020 - 11/2005
2
Conditioned Culture Media
IBA
12/2018 - 01/2014
2
Glucose (Dextrose)
FDA Link
Generic
01/2018 - 01/2017
2
tyrosine receptor (receptor, tyrosine)
IBA
02/2016 - 11/2011
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
02/2016 - 02/2012
2
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
01/2016 - 11/2007
2
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
12/2015 - 11/2011
2
Interleukin-17 (Interleukin 17)
IBA
06/2015 - 12/2011
2
Luciferases
IBA
02/2014 - 12/2010
2
Interleukin-15 (Interleukin 15)
IBA
02/2014 - 01/2014
2
Paclitaxel (Taxol)
FDA Link
Generic
01/2014 - 07/2003
2
Defensins
IBA
10/2012 - 05/2012
2
Azoxymethane
IBA
12/2011 - 05/2011
2
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
11/2011 - 11/2008
2
Tyrosine Kinase Inhibitors
IBA
11/2011 - 06/2007
2
Activating Transcription Factor 3
IBA
12/2010 - 11/2007
2
fumarylacetoacetase (fumarylacetoacetate hydrolase)
IBA
05/2010 - 11/2008
2
NF-kappa B (NF-kB)
IBA
04/2010 - 02/2009
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
08/2009 - 11/2008
2
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
11/2008 - 06/2007
2
Focal Adhesion Protein-Tyrosine Kinases
IBA
11/2007 - 03/2007
2
tanespimycin (17AAG)
IBA
11/2007 - 03/2007
2
Green Fluorescent Proteins
IBA
03/2004 - 01/2003
Therapy/Procedure
30
Therapeutics
11/2023 - 03/2004
13
Transplantation
02/2021 - 11/2008
11
Liver Transplantation
03/2024 - 11/2004
10
Organ Transplantation
08/2015 - 01/2002
4
Heart Transplantation (Grafting, Heart)
01/2020 - 05/2004
2
Immunomodulation
01/2023 - 01/2020
2
Negative-Pressure Wound Therapy
11/2020 - 11/2019
2
Ligation
01/2020 - 03/2017
2
Drug Therapy (Chemotherapy)
03/2017 - 03/2004